Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles
Life Science Alliance · 2024
DOI: 10.26508/lsa.202302509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Eva Habjan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands. Hauptthemen laut MEDLINE: Zebrafish, Benzothiazoles, Drug Synergism, Mycobacterium marinum. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Developing effective tuberculosis drugs is hindered by mycobacteria’s intrinsic antibiotic resistance because of their impermeable cell envelope. Using benzothiazole compounds, we aimed to increase mycobacterial cell envelope permeability and weaken the defenses of Mycobacterium marinum , serving as a model for Mycobacterium tuberculosis . Initial hit, BT-08, significantly boosted ethidium bromide uptake, indicating enhanced membrane permeability. It also demonstrated efficacy in the M. marinum –zebrafish embryo infection model and M. tuberculosis -infected macrophages. Notably, BT-08 synergized with established antibiotics, including vancomycin and rifampicin. Subsequent medicinal chemistry optimization led to BT-37, a non-toxic and more potent derivative, also enhancing ethidium bromide uptake and maintaining synergy with rifampicin in infected zebrafish embryos. Mutants of M. marinum resistant to BT-37 revealed that MMAR_0407 (Rv0164) is the molecular target and that this target plays a role in the observed synergy and permeability. This study introduces novel compounds targeting a new mycobacterial vulnerability and highlights their cooperative and synergistic interactions with existing antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands.
- Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), Moscow, Russia.
- Federal Research Centre "Fundamentals of Biotechnology" of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), Moscow, Russia makarov@inbi.ras.ru.
- Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Location VU Medical Center, Amsterdam, Netherlands a.speer@amsterdamumc.nl.
ORCID-Profile: Eva Habjan, Anna Egorova, Vien Qt Ho, Vadim Makarov, Alexander Speer
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Habjan, E., Lepioshkin, A., Charitou, V., Egorova, A., Kazakova, E., Ho, V. Q., Bitter, W., Makarov, V., & Speer, A. (2024). Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles. Life Science Alliance. https://doi.org/10.26508/lsa.202302509
Vancouver
Habjan E, Lepioshkin A, Charitou V, Egorova A, Kazakova E, Ho VQ, et al. Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles. Life Science Alliance. 2024. doi:10.26508/lsa.202302509
BibTeX
@article{Habjan2024,
author = {Habjan, Eva and Lepioshkin, Alexander and Charitou, Vicky and Egorova, Anna and Kazakova, Elena and Ho, Vien Qt and Bitter, Wilbert and Makarov, Vadim and Speer, Alexander},
title = {Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202302509}
}
EUVIMED